Focal Therapy for Prostate Cancer: Is It Being Oversold? Focal Therapy for Prostate Cancer: Is It Being Oversold?

Despite growing enthusiasm for this minimally invasive option for some men with prostate cancer, focal therapy is still not FDA-approved for prostate cancer and comes with high out-of-pocket costs.Medscape Medical News
Source: Medscape Urology Headlines - Category: Urology & Nephrology Tags: Hematology-Oncology Source Type: news